Upstate Active Clinical Trials

Study Title:

A Randomized Phase 3 Study Comparing Cabazitaxel/Prednisone In Combination with Custirsen(OGX-011) to Cabazitaxel/Prednisone for Second-Line Chemotherapy in Men with Metastatic Castrate Resistant Prostate Cancer(Protocol#OGX-011-12)

Upstate Institutional Review Board (IRB) Number:

373201

Study Phase:

III

Patient Age Group:

Adults

Principal Investigator:

Bernard J Poiesz, MD

ClinicalTrials.Gov ID:

NCT01578655

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Patricia M Benz
Phone: 315-464-8253
Email: benzp@upstate.edu

Return to Previous Page || Search Again